The 'very efficient' almond market and rising land values are probably among the factors that just prompted AgIS Capital to buy a 952-acre property for a reported $24m.
The fund, which has invested in water rights and almonds through the Brisbane-based manager, is monitoring the situation due to potential reputational risk.
The A$50m asset is the first to be broken off from the company’s wider portfolio, which is still subject to a sale process.
Pivot Bio chief executive Karsten Temme says the nitrogen-producing microbe business, which just closed a $70m Series B, could help upend a market worth about $200bn.
The US firm has agreed to invest A$50m in the embattled Australian manager through a convertible loan note. Blue Sky says this is a positive move for the business – but investors probably need more convincing.
Managing partner Jeffrey Howard says Front Range Biosciences is among the companies benefiting from a surge in private investor interest in cannabis.
Founding partner Stuart Bradley says the private equity firm has deliberately aimed to increase the participation of private investors in its second vehicle, which already counts OPIC and the AfDB among its LPs.
Alvaro Pino, investment officer at the Dutch development bank, tells Agri Investor that DFIs and impact investors remain the main source of capital for all but the largest participants in the South American nation’s agricultural economy.
Sources say the addition of a $171m Pacific Northwest property to an entity containing Mississippi Delta assets comes amid signs the Microsoft founder's vehicles are increasing exposure to US farmland.
We catch up with New Forests chief executive David Brand as the firm starts to deploy its A$873m third fund dedicated to the region.